Healthcare Professionals
Affinity Pixie
Arterial Filter
Affinity Pixie Arterial Filter
One filter gives you the flexibility for both your infant and pediatric patients.
Overview
A pediatric arterial filter featuring ease of prime and effective air handling and filtration.
LOW PRIME
With just 39 mL prime volume, the Affinity Pixie™ Arterial Filter is used as part of strategies to minimize prime volume contribution to hemodilution.
HIGH MAXIMUM RECOMMENDED FLOW RATE
The filter’s maximum recommended flow rate of 3.2 L/min exceeds that of competing arterial filters and provides versatility of use with different patient sizes.
EXCELLENT FILTRATION
Effective filtration is provided by the unique 30 micron concentric folded screen design that maximizes the available filtration surface area within a small filter housing.
EASE OF PRIME, EFFECTIVE AIR HANDLING, AND EXCELLENT VISIBILITY
The Affinity Pixie Arterial Filter has been designed to have no “hidden” areas, such as opaque screen caps or urethane pleating and netting where air and particulate can become trapped. Horizontal surfaces are reduced for minimal bubble hang-up. The filter housing is completely clear for excellent visibility.
LOWER PRESSURE DROP
Just 30 mmHg pressure drop at the maximum flow rate of 3.2 L/min for gentle blood handling.
PEDIATRIC ARTERIAL FILTERS: COMPETITIVE COMPARISON
|
|
Prime Volume (mL) |
Screen Pore Size (microns) |
Maximum Recommended Blood Flow Rate (L/min) |
Pressure Drop at 2.5 L/min Blood Flow Rate |
|---|---|---|---|---|
| Medtronic Affinity Pixie™ Arterial Filter |
39 |
30 |
3.2 |
15 |
| Terumo CAPIOX® |
40 |
32 |
2.5 |
25 |
| Sorin Micro D7352 |
40 |
27 |
2.5 |
> 60 |
| Sorin Micro D7362 |
40 |
40 |
2.5 |
> 60 |
CORTIVA™ BIOACTIVE SURFACE AND BALANCE™ BIOSURFACE OPTIONS
- Durable, non-leaching End Point Attached heparin
- Provides thromboresistance and enhanced blood compatibility
- A hydrophilic biosurface option without heparin
- Reduces platelet activation
- Reduces platelet adhesion
- Preserves platelet function4
For more information, including product specifications and ordering information, download our product brochure.
ORDERING INFORMATION
| Arterial Filters |
||
|---|---|---|
| Note: All filters with bypass circuits include a purge line with a valve and stopcock. Intersept™ Pre-bypass Filters and Intersept Crystalloid Cardioplegia Filter available in Tubing Packs only. |
||
| Order Number |
Description |
# of Units |
| 351 |
Affinity™ Arterial Filter 212 ml volume, 3/8” Inlet, 3/8” Outlet, 38 micron screen |
Tubing packs only |
| 352 |
Affinity Arterial Filter with Bypass 212 mL volume, 3/8” Inlet, 3/8” Outlet, 38 micron screen |
Tubing packs only |
| 353 |
Affinity Arterial Filter 212 ml volume, 3/8” Inlet, 3/8” Outlet, 20 micron screen |
Tubing packs only |
| 354 |
Affinity Arterial Filter with Bypass 212 ml volume, 3/8” Inlet, 3/8” Outlet, 20 micron screen |
Tubing packs only |
| S4014 |
Affinity Pixie™ Arterial Filter, 39 ml volume, 1/4” Inlet, 1/4” Outlet, 30 micron screen |
4 per case |
| CB4014 |
Affinity Pixie Arterial Filter with Cortiva™ BioActive Surface, 39 ml volume, 1/4” Inlet, 1/4” Outlet, 30 micron screen |
Tubing packs only |
| BB4014 |
Affinity Pixie Arterial Filter with Balance Biosurface, 39 ml volume, 1/4” Inlet, 1/4” Outlet, 30 micron screen |
Tubing packs only |
| Arterial Filter Holders |
||
|---|---|---|
| 61399401119 |
Affinity™ Arterial Filter Holder — one piece |
1 |
| HR4014 |
Holder for Series 4014 Arterial Filters |
1 |
REFERENCES
1. Terumo® Cardiovascular Systems website. Accessed 11/07.
2. Sorin product literature. Part Number 306350076 Rev A (06/06).
3. Balance™ is a registered trademark of Medtronic, Inc. Technology licensed under agreement from BioInteractions, Limited, United Kingdom.
4. See chart below.
Comparison between Balance-coated and uncoated in vitro bench test circuits of percentage of platelets that are activated with adenosine diphosphate (ADP @20 μM) in circulating heparinized human blood over time. Error bars represent standard deviation. († indicates p < 0.05)
Warnings: A strict anticoagulation protocol should be followed and anticoagulation should be routinely monitored during all procedures. The benefits of extracorporeal support must be weighed against the risk of systematic anticoagulation and must be assessed by the prescribing physician.
Caution: Federal law (USA) restricts devices coated with Cortiva™ BioActive Surface and Balance Biosurface to sale by or on the order of a physician. For a complete listing of indicatons, contraindications, precautions and warnings, please refer to the Instructions for Use which accompany each product.